Key facts
- This page summarizes Opaleye Management Inc.'s Form 4 filing for TELA Bio, Inc. (TELA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Apr 2023, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
Additional SEC filing notes
Section 16 status
Opaleye Management Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to own the securities owned directly by the Managed Account.
Footnote F2
Represents securities directly owned by Opaleye, L.P. ("the fund"). As the investment manager of the Fund, Opaleye Management may be deemed to own the securities owned directly by the Fund.